HLS Therapeutics Inc.

TSX:HLS 株式レポート

時価総額:CA$108.7m

HLS Therapeutics 将来の成長

Future 基準チェック /16

HLS Therapeuticsは、49.2%と8.6%でそれぞれ年率49.2%で利益と収益が成長すると予測される一方、EPSはgrowで52.4%年率。

主要情報

49.2%

収益成長率

52.4%

EPS成長率

Pharmaceuticals 収益成長53.6%
収益成長率8.6%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日22 Nov 2024

今後の成長に関する最新情報

Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

May 12
Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

Recent updates

Are Investors Undervaluing HLS Therapeutics Inc. (TSE:HLS) By 45%?

Oct 26
Are Investors Undervaluing HLS Therapeutics Inc. (TSE:HLS) By 45%?

Pinning Down HLS Therapeutics Inc.'s (TSE:HLS) P/S Is Difficult Right Now

Sep 28
Pinning Down HLS Therapeutics Inc.'s (TSE:HLS) P/S Is Difficult Right Now

Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

May 12
Analysts Have Lowered Expectations For HLS Therapeutics Inc. (TSE:HLS) After Its Latest Results

After Leaping 29% HLS Therapeutics Inc. (TSE:HLS) Shares Are Not Flying Under The Radar

Apr 14
After Leaping 29% HLS Therapeutics Inc. (TSE:HLS) Shares Are Not Flying Under The Radar

Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Apr 06
Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Analysts Are More Bearish On HLS Therapeutics Inc. (TSE:HLS) Than They Used To Be

Nov 16
Analysts Are More Bearish On HLS Therapeutics Inc. (TSE:HLS) Than They Used To Be

Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Sep 13
Here's Why HLS Therapeutics (TSE:HLS) Can Afford Some Debt

Would HLS Therapeutics (TSE:HLS) Be Better Off With Less Debt?

May 05
Would HLS Therapeutics (TSE:HLS) Be Better Off With Less Debt?

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Apr 05
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05

Mar 20
HLS Therapeutics (TSE:HLS) Is Paying Out A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05

Nov 30
HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05

Downgrade: Here's How Analysts See HLS Therapeutics Inc. (TSE:HLS) Performing In The Near Term

Nov 11
Downgrade: Here's How Analysts See HLS Therapeutics Inc. (TSE:HLS) Performing In The Near Term

We Think HLS Therapeutics (TSE:HLS) Has A Fair Chunk Of Debt

Sep 14
We Think HLS Therapeutics (TSE:HLS) Has A Fair Chunk Of Debt

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Aug 15
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

Jul 14
HLS Therapeutics (TSE:HLS) Is Due To Pay A Dividend Of $0.05

HLS Therapeutics (TSE:HLS) Has Announced A Dividend Of CA$0.05

Jun 23
HLS Therapeutics (TSE:HLS) Has Announced A Dividend Of CA$0.05

HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

Jun 08
HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

May 25
HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

May 10
HLS Therapeutics' (TSE:HLS) Dividend Will Be CA$0.05

Time To Worry? Analysts Are Downgrading Their HLS Therapeutics Inc. (TSE:HLS) Outlook

Apr 30
Time To Worry? Analysts Are Downgrading Their HLS Therapeutics Inc. (TSE:HLS) Outlook

HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05

Apr 15
HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of CA$0.05

HLS Therapeutics (TSE:HLS) Has Re-Affirmed Its Dividend Of CA$0.05

Mar 26
HLS Therapeutics (TSE:HLS) Has Re-Affirmed Its Dividend Of CA$0.05

HLS Therapeutics Inc. (TSE:HLS) Analysts Just Slashed This Year's Estimates

Mar 22
HLS Therapeutics Inc. (TSE:HLS) Analysts Just Slashed This Year's Estimates

業績と収益の成長予測

TSX:HLS - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202667-7N/AN/A1
12/31/202561-917175
12/31/202457-19445
9/30/202457-22229N/A
6/30/202459-241212N/A
3/31/202461-281213N/A
12/31/202363-281616N/A
9/30/202363-291516N/A
6/30/202363-26414N/A
3/31/202362-26515N/A
12/31/202261-24717N/A
9/30/202261-21717N/A
6/30/202261-191617N/A
3/31/202260-121215N/A
12/31/202160-131216N/A
9/30/202161-161118N/A
6/30/202159-16-2217N/A
3/31/202157-20-2811N/A
12/31/202056-15-359N/A
9/30/202054-20-416N/A
6/30/202054-21-910N/A
3/31/202055-16423N/A
12/31/201954-201126N/A
9/30/201957-71135N/A
6/30/201959-252235N/A
3/31/201961-241428N/A
12/31/201861-251833N/A
9/30/201865-262830N/A
6/30/201870-8N/A33N/A
3/31/201873-8N/A37N/A
12/31/201775-6N/A27N/A
9/30/201771-11N/A25N/A
12/31/201654-15N/A22N/A
12/31/201520-10N/A-6N/A

アナリストによる今後の成長予測

収入対貯蓄率: HLS今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: HLS今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: HLS今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: HLSの収益 ( 8.6% ) Canadian市場 ( 7% ) よりも速いペースで成長すると予測されています。

高い収益成長: HLSの収益 ( 8.6% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: HLSの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘